Drug
Biib074
Biib074: highest development phase Phase 1, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| BIIB074 NCT02751905 | Phase 1 | Neuropathic Pain |
Latest
No recent events.
Follow Biib074 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.